INTRON BIOTECHNOLOGY, INC. financial statements, including revenue, expenses, profit, and loss

The total revenue of 048530 for the last quarter is 1.21 B KRW, and it's 32.03% lower compared to the previous quarter. The net income of Q3 24 is -1.32 B KRW.